DOSE ESCALATION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG)

Published

Conference Paper

ATIM-16

Full Text

Duke Authors

Cited Authors

  • Desjardins, A; Randazzo, D; Chandramohan, V; Peters, K; Johnson, M; Thomas, L; Threatt, S; Bullock, C; Herndon, J; Boulton, S; Healy, P; Lipp, E; Sampson, J; Friedman, A; Friedman, H; Ashley, D; Bigner, D

Published Date

  • November 5, 2018

Published In

Volume / Issue

  • 20 / suppl. 6; abstr ATIM-36

Start / End Page

  • vi9 - vi9

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1523-5866

International Standard Serial Number (ISSN)

  • 1522-8517

Digital Object Identifier (DOI)

  • 10.1093/neuonc/noy148.031

Conference Name

  • 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference

Conference Location

  • New Orleans, LA

Conference Start Date

  • November 14, 2018

Conference End Date

  • November 18, 2018